Literature DB >> 33420252

Chlamydia trachomatis intra-bacterial and total plasmid copy number in clinical urogenital samples.

J A M C Dirks1,2, K Janssen3,4, C J P A Hoebe3,4, T H B Geelen3, M Lucchesi3, N H T M Dukers-Muijrers3,4, P F G Wolffs3.   

Abstract

Chlamydia trachomatis (CT) increases its plasmid numbers when stressed, as occurs in clinical trachoma samples. Most CT tests target the plasmid to increase the test sensitivity, but some only target the chromosome. We investigated clinical urogenital samples for total plasmid copy numbers to assess its diagnostic value and intra-bacterial plasmid copy numbers to assess its natural variation. Both plasmid and chromosome copies were quantified using qPCR, and the plasmid:chromosome ratio (PCr) calculated in two cohorts: (1) 383 urogenital samples for the total PCR (tPCr), and (2) 42 vaginal swabs, with one half treated with propium-monoazide (PMA) to prevent the quantification of extracellular DNA and the other half untreated to allow for both tPCr and intra-bacterial PCr (iPCr) quantification. Mann-Whitney U tests compared PCr between samples, in relation to age and gender. Cohort 1: tPCr varied greatly (1-677, median 16). Median tPCr was significantly higher in urines than vaginal swabs (32 vs. 11, p < 0.001). Cohort 2: iPCr was more stable than tPCr (range 0.1-3 vs. 1-11). To conclude, tPCr in urogenital samples was much more variable than previously described. Transport time and temperature influences DNA degradation, impacting chromosomal DNA more than plasmids and urine more than vaginal samples. Data supports a plasmid target in CT screening assays to increase clinical sensitivity.

Entities:  

Year:  2021        PMID: 33420252      PMCID: PMC7794532          DOI: 10.1038/s41598-020-80645-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  26 in total

1.  A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests.

Authors:  T Ripa; P Nilsson
Journal:  Euro Surveill       Date:  2006-11-09

2.  Selective removal of DNA from dead cells of mixed bacterial communities by use of ethidium monoazide.

Authors:  Andreas Nocker; Anne K Camper
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

Review 3.  Risk of sequelae after Chlamydia trachomatis genital infection in women.

Authors:  Catherine L Haggerty; Sami L Gottlieb; Brandie D Taylor; Nicola Low; Fujie Xu; Roberta B Ness
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  Identification of a Chlamydia trachomatis serovar E urogenital isolate which lacks the cryptic plasmid.

Authors:  D R Stothard; J A Williams; B Van Der Pol; R B Jones
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 5.  Prevalence and significance of plasmid maintenance functions in the virulence plasmids of pathogenic bacteria.

Authors:  Manjistha Sengupta; Stuart Austin
Journal:  Infect Immun       Date:  2011-05-09       Impact factor: 3.441

6.  The plasmids of Chlamydia trachomatis and Chlamydophila pneumoniae (N16): accurate determination of copy number and the paradoxical effect of plasmid-curing agents.

Authors:  Mark A Pickett; J Sylvia Everson; Patrick J Pead; Ian N Clarke
Journal:  Microbiology (Reading)       Date:  2005-03       Impact factor: 2.777

7.  The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism.

Authors:  E M Peterson; B A Markoff; J Schachter; L M de la Maza
Journal:  Plasmid       Date:  1990-03       Impact factor: 3.466

Review 8.  Unraveling the basic biology and clinical significance of the chlamydial plasmid.

Authors:  Daniel D Rockey
Journal:  J Exp Med       Date:  2011-10-24       Impact factor: 14.307

9.  Chlamydia trachomatis load in population-based screening and STI-clinics: implications for screening policy.

Authors:  Jeanne A M C Dirks; Petra F G Wolffs; Nicole H T M Dukers-Muijrers; Antoinette A T P Brink; Arjen G C L Speksnijder; Christian J P A Hoebe
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

10.  Viability-PCR Shows That NAAT Detects a High Proportion of DNA from Non-Viable Chlamydia trachomatis.

Authors:  Kevin J H Janssen; Christian J P A Hoebe; Nicole H T M Dukers-Muijrers; Lisanne Eppings; Mayk Lucchesi; Petra F G Wolffs
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.